Pharmacokinetics and immunogenicity of eftozanermin alfa in subjects with previously-treated solid tumors or hematologic malignancies: results from a phase 1 first-in-human study.

Bibliographic Details
Published in:Cancer Chemotherapy & Pharmacology Vol. 93; no. 4; pp. 329 - 340
Main Authors: Biesdorf, Carla, Guan, Xiaowen, Siddani, Satya R., Hoffman, David, Boehm, Nils, Medeiros, Bruno C., Doi, Toshihiko, de Jonge, Maja, Rasco, Drew, Menon, Rajeev M., Polepally, Akshanth R.
Format: Journal Article
Published: Springer Nature Apr2024
Online Access:View this record in EBSCOhost